6.17 : Drugs Affecting Neurotransmitter Release or Uptake

Some drugs that act on the adrenergic neurons can disrupt catecholamine release from synaptic vesicles or interfere with neurotransmitter reuptake.

Reserpine, an alkaloid, blocks the transport of catecholamine into synaptic vesicles, leading to the accumulation of catecholamines in the cytosol. Eventually, they are degraded by MAO, reducing sympathetic transmission.

Guanethidine, a sympatholytic agent, enters the nerve endings and accumulates in synaptic vesicles, displacing noradrenaline. This impedes vesicular exocytosis and neurotransmitter release at the synapse, blocking impulse conduction.

Higher doses of guanethidine can cause structural aberrations in the neuron.

Noradrenaline, when released into the synaptic space, undergoes reuptake via the norepinephrine transporter. Inhibitors of this transporter include serotonin-noradrenaline reuptake inhibitors like duloxetine, tricyclic antidepressants like imipramine, and indirect-acting agonists like cocaine.

Due to their associated side effects, these drugs have limited therapeutic use and have been largely replaced by more selective agents.

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking neurotransmitter release and uptake by targeting the catecholamine transporter NET. It can also enter synaptic vesicles and displace noradrenaline. Some other drugs like duloxetine, imipramine, and cocaine also inhibit this transporter. Cocaine, in particular, enhances sympathetic activity by obstructing the reuptake of catecholamines. While these drugs have been studied experimentally, only a few have been used clinically. Newer and more selective drugs have made some of these compounds outdated. However, understanding how these drugs affect the release and reuptake of catecholamines is essential for potential treatments of various disorders.

Tags

Neurotransmitters Catecholamines Sympathetic Transmission Reserpine Vesicular Monoamine Transporter VMAT Guanethidine Norepinephrine Transporter NET Duloxetine Imipramine Cocaine Reuptake Inhibition Drug Effects Clinical Use

Dal capitolo 6:

article

Now Playing

6.17 : Drugs Affecting Neurotransmitter Release or Uptake

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

892 Visualizzazioni

article

6.1 : Neuroni adrenergici: neurotrasmissione

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

3.3K Visualizzazioni

article

6.2 : Recettori adrenergici (Adrenocettori): Classificazione

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

2.1K Visualizzazioni

article

6.3 : Recettori adrenergici: ɑ Sottotipo

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

1.3K Visualizzazioni

article

6.4 : Recettori adrenergici: sottotipo β

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

1.4K Visualizzazioni

article

6.5 : Agonisti adrenergici: agenti ad azione diretta

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

1.3K Visualizzazioni

article

6.6 : Agonisti adrenergici: agenti ad azione indiretta

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

1.4K Visualizzazioni

article

6.7 : Agonisti adrenergici: agenti ad azione mista

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

632 Visualizzazioni

article

6.8 : Agonisti adrenergici: chimica e relazione struttura-attività

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

2.5K Visualizzazioni

article

6.9 : Agonisti adrenergici: classificazione terapeutica

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

653 Visualizzazioni

article

6.10 : Agonisti adrenergici: usi terapeutici

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

693 Visualizzazioni

article

6.11 : Antagonisti adrenergici: chimica e classificazione dei bloccanti del recettore ɑ

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

769 Visualizzazioni

article

6.12 : Antagonisti adrenergici: azioni farmacologiche dei bloccanti del recettore ɑ

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

514 Visualizzazioni

article

6.13 : Antagonisti adrenergici: chimica e classificazione dei bloccanti del β-recettore

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

475 Visualizzazioni

article

6.14 : Antagonisti adrenergici: azioni farmacologiche dei bloccanti del β-recettore

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

504 Visualizzazioni

See More

Copyright © 2025 MyJoVE Corporation. Tutti i diritti riservati